Marc Odrich

Chief Medical OfficeratLENZ Therapeutics· In proxies 2023–2025

Pay in FY2025+20% from the year before · LENZ Therapeutics stock -44.6% the same year

Marc Odrich was paid $2.4M in FY2025 (Dec), up 20%. LENZ Therapeutics stock fell 44.6% that year.

Pay$100 in the stock at the end of FY22 → $102

Pay is from the Summary Compensation Table of each LENZ Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

LENZ
LENZ TherapeuticsPublic company · 3 yr
- Chief Medical Officer2023 – Present · 3 yrStock in role -76%

Roles come from the proxy statements of each company.

Activity

Pay
LENZ Therapeutics Chief Medical Officer pay rose 20% to $2.4M. The stock fell 45% in FY2025 (Dec).
DEF 14AApr 28, 2026
Pay
LENZ Therapeutics Chief Medical Officer pay rose 122% to $2.0M. The stock rose 133% in FY2024 (Dec).
DEF 14AApr 28, 2025

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?